↓ Skip to main content

Dove Medical Press

Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways

Overview of attention for article published in Drug Design, Development and Therapy, July 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
20 Mendeley
Title
Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways
Published in
Drug Design, Development and Therapy, July 2022
DOI 10.2147/dddt.s356307
Pubmed ID
Authors

Juan-Juan Cheng, Xing-Dong Ma, Gao-Xiang Ai, Qiu-Xia Yu, Xiao-Ying Chen, Fang Yan, Yu-Cui Li, Jian-Hui Xie, Zi-Ren Su, Qing-Feng Xie

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 2 10%
Lecturer 2 10%
Student > Bachelor 2 10%
Student > Doctoral Student 1 5%
Professor 1 5%
Other 2 10%
Unknown 10 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 15%
Medicine and Dentistry 2 10%
Agricultural and Biological Sciences 2 10%
Nursing and Health Professions 1 5%
Immunology and Microbiology 1 5%
Other 1 5%
Unknown 10 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2022.
All research outputs
#16,279,421
of 25,707,225 outputs
Outputs from Drug Design, Development and Therapy
#943
of 2,278 outputs
Outputs of similar age
#225,576
of 441,460 outputs
Outputs of similar age from Drug Design, Development and Therapy
#13
of 51 outputs
Altmetric has tracked 25,707,225 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,278 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 441,460 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.